Gilead Sciences, Inc.
Long
Updated

COVID-19 Vaccine, 1st Effective Drug, USA Secures 500,000 Doses

246
HHS secures 500,000 doses of remdesivir.

The Trump administration has secured 500,000 doses of remdesivir, the first drug shown to be effective at treating hospitalized coronavirus patients, ensuring these doses will be for U.S. use.

This could mean huge profits for GILD.

Indicators are starting to turn up, Bullish.

Daily Chart is turning Bullish.

I think if the stock breaks above the $77.00 range, it's going to spike.

Long!

DISCLAIMER
The Content herein is for informational purposes only, you should not construe any such information or other material as legal, tax, investment, financial, or other advice.
Note
EU could approve remdesivir any day.

On 06/25/2020, EU has recommended granting GILD authorization for Remdesivir.

Watch for the news!

Disclaimer

The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.